Back to Search
RICHARD GRALLA, MD
MD
Hematology & Oncology Physician
NPI: 1710167002Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
119133(NY)
Research & Publications (20)
Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancer.
PMID 19188545·Chest·2009
3-trial
Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS).
PMID 18781341·Support Care Cancer·2009
8-other
Oral vinorelbine in the treatment of non-small cell lung cancer: rationale and implications for patient management.
PMID 17600389·Drugs·2007
6-review
The 2004 Perugia Antiemetic Consensus Guideline process: methods, procedures, and participants.
PMID 15605253·Support Care Cancer·2005
8-other
Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin: analysis of combined data from two Phase III randomized clinical trials.
PMID 15973669·Cancer·2005
3-trial
Quality-of-life assessment in advanced lung cancer: considerations for evaluation in patients receiving chemotherapy.
PMID 15698531·Lung Cancer·2004
6-review
Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron.
PMID 14504060·Ann Oncol·2003
3-trial
Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials.
PMID 18565615·Lung Cancer·2009
1-meta
Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia.
PMID 18235119·J Clin Oncol·2008
4-observational
Lung Cancer Symptom Scale outcomes in relation to standard efficacy measures: an analysis of the phase III study of pemetrexed versus docetaxel in advanced non-small cell lung cancer.
PMID 18166838·J Thorac Oncol·2008
8-other
Neoadjuvant chemotherapy with gemcitabine-containing regimens in patients with early-stage non-small cell lung cancer.
PMID 18166839·J Thorac Oncol·2008
3-trial
Interpreting clinical trials in lung cancer: impact of methodology and endpoints.
PMID 17589300·J Thorac Oncol·2007
6-review
An introduction to Current Opinion in Supportive and Palliative Care.
PMID 18660715·Curr Opin Support Palliat Care·2007
8-other
Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC antiemesis tool.
PMID 17509816·J Pain Symptom Manage·2007
8-other
American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.
PMID 16717289·J Clin Oncol·2006
6-review
Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis.
PMID 18632487·Support Cancer Ther·2006
8-other
Update on the management of chemotherapy-related nausea and vomiting: an emphasis on the new class of agents--neurokinin-1 receptor antagonists.
PMID 17147235·Clin Adv Hematol Oncol·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 450 LAKEVILLE RD
NEW HYDE PARK, NY 11042 - Phone
- (516) 734-8900
Quick Facts
- NPI
- 1710167002
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile